Russia - Press Releases

WASHINGTON, 12 de marzo de 2025 /PRNewswire/ -- Gallup ha nombrado a 70 ganadores del Premio Gallup al Lugar de Trabajo Excepcional (GEWA) 2025, incluidos 62 ganadores por compromiso de los empleados, 12 ganadores por desarrollo de fortalezas y 7 ganadores con distincin.

BARCELONA, Spanien, 12. Mrz 2025 /PRNewswire/ -- Whrend des MWC 2025 stellte Huawei die aktualisierte FTTO 2.0-Lsung vor, welche die Entwicklung von 10G-Campusnetzwerken anfhrt.

NEW YORK, March 12, 2025 /PRNewswire/ -- SPS North America, a leading outsourcing provider for business process solutions and innovative services in data management, has been selected by Cigna Healthcare as a recipient of their 2024 silver level Healthy Workforce Designation for demonstrating SPS' strong commitment to improving the health and vitality of its employees through a workplace well-being program.

New generative AI tool on ScienceDirect, the world's largest platform for peer-reviewed research used by millions of researchers each day, saves half of literature research time, supports better outcomes

Die erste ETF-Anmeldung von Movementermglicht US-Anlegern ein Engagement im kosystem von Movement

Omada Identity Cloud se alinea a la perfeccin para una gestin de identidad y acceso slida y eficiente

New 64-inch Innovative Solvent Printer Delivers Extreme Color Gamut andAdvanced Performance in New Compact and Sleek Design

BEIJING, March 10, 2025 /PRNewswire/ -- A news report from Beijing Review:

PETAH TIKVA, Isral, 10 mars 2025 /PRNewswire/ -- Isotopia, l'un des principaux dveloppeurs de produits radio-pharmaceutiques innovants, a officiellement lanc Isoprotrace en Allemagne. DSD Pharma, distributeur pharmaceutique de confiance en Allemagne, sera le partenaire exclusif pour la distribution d'Isoprotrace dans tout le pays, assurant une livraison efficace et cohrente aux hpitaux, cliniques et centres de diagnostic dans toute l'Allemagne. Ce partenariat s'tend galement la distribution de notre chlorure de lutcium (177 Lu) n.c.a., ce qui renforce encore notre portefeuille de solutions avances d'imagerie et de traitement du cancer.

PETAH TIKVA, Israel, 10. Mrz 2025 /PRNewswire/ -- Isotopia, ein fhrender Entwickler von innovativen Radiopharmazeutika, hat Isoprotrace offiziell in Deutschland eingefhrt. DSD Pharma, ein vertrauenswrdiger Pharmahndler in Deutschland, wird als exklusiver Partner fr den Vertrieb von Isoprotrace im ganzen Land fungieren und eine effiziente, konsistente Lieferung an Krankenhuser, Kliniken und Diagnosezentren in ganz Deutschland sicherstellen. Diese Partnerschaft erstreckt sich auch auf den Vertrieb unseres Lutetium (177 Lu)-Chlorids n.c.a., wodurch unser Portfolio an fortschrittlichen Lsungen fr die Krebsbildgebung und -behandlung weiter ausgebaut wird.

PETAH TIKVA, Israel, March 10, 2025 /PRNewswire/ -- Isotopia, a leading developer of innovative radio-pharmaceuticals, has officially launched Isoprotrace in Germany. DSD Pharma, a trusted pharmaceutical distributor in Germany, will serve as the exclusive partner for the distribution of Isoprotrace throughout the country, ensuring efficient, consistent delivery to hospitals, clinics, and diagnostic centres across Germany. This partnership also extends to the distribution of our Lutetium (177 Lu) Chloride n.c.a., further enhancing our portfolio of advanced cancer imaging and treatment solutions.

PETAH TIKVA, Israel, March 10, 2025 /PRNewswire/ -- Isotopia, a leading developer of innovative radio-pharmaceuticals, has officially launched Isoprotrace in Germany. DSD Pharma, a trusted pharmaceutical distributor in Germany, will serve as the exclusive partner for the distribution of Isoprotrace throughout the country, ensuring efficient, consistent delivery to hospitals, clinics, and diagnostic centres across Germany. This partnership also extends to the distribution of our Lutetium (177 Lu) Chloride n.c.a., further enhancing our portfolio of advanced cancer imaging and treatment solutions.

VARSOVIA, Polonia, 7 de marzo de 2025 /PRNewswire/ --Cuidar una sonrisa sana y bonita es una parte fundamental de la rutina diaria, pero los enfoques en la higiene bucal difieren segn el gnero. Un estudio realizado por la firma de investigacin y anlisis independiente IQS, encargado por la marca Oclean, demuestra que las mujeres visitan al dentista con ms frecuencia y son ms constantes a la hora de cepillarse los dientes. Los hombres, en cambio, tienden a centrarse en la funcionalidad y la simplicidad, optando por soluciones rpidas y eficaces.

SAN DIEGO, March 10, 2025 /PRNewswire/ -- While participation in pickleball and other sports is growing, data on returning to play after joint arthroplasty (JA) is limited. Presented at the 2025 Annual Meeting of the American Academy of Orthopaedic Surgeons(AAOS), a new study found that a majority of patients who played racket sports were able to return to play after JA within six months and at a similar skill level without an increase in reoperation rates. Patients who returned to play also had higher physical function scores after surgery compared to those who did not return to play.

SAN DIEGO, March 10, 2025 /PRNewswire/ -- Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity. However, their use in the perioperative period surrounding major surgeries, like total joint arthroplasty (TJA), remains an area of growing interest and concern. A new study presented at the 2025 Annual Meeting of theAmerican Academy of Orthopaedic Surgeons(AAOS) examined how the timing of a patient's last dose of Ozempic prior to total knee arthroplasty (TKA) or total hip arthroplasty (THA) influences anesthesia-related complications such as delayed emergence, aspiration, aspiration pneumonitis and conversion to intubation. The study found that discontinuing semaglutide two weeks before surgery lowered a patient's risk for these complications.

SAN DIEGO, March 10, 2025 /PRNewswire/ -- Prior authorization is commonly used with commercial insurance companies as a cost-controlling policy. However, a study presented at the 2025 Annual Meeting of theAmerican Academy of Orthopaedic Surgeons(AAOS) found that prior authorization was an ineffective cost-saving measure for patients undergoing primary total hip arthroplasty (THA). The study, "Prior Authorization Does Not Reduce Costs in Patients Undergoing Primary Total Hip Arthroplasty," also saw lower preoperative functional outcomes scores and significantly longer wait times before surgery when prior authorization was required. It is the first study to quantify the time and costs associated with obtaining prior authorization in patients undergoing THA.

SAN DIEGO, March 10, 2025 /PRNewswire/ -- Living with osteoarthritis not only affects a person's quality of life but can greatly impact their spouse's quality of life. Anew study found that spouses experience significant improvements in quality of life after their partner undergoes total hip or knee arthroplasty (THA, TKA). Presented at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting, it is among the first to demonstrate this positive impact.

VALBY, Denmark, March 10, 2025 /PRNewswire/ --The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).

Increase in health consciousness, fitness participation, athleisure adoption, and disposable income have driven the global workout clothes market. Advancements in fabric technology, demand for moisture-wicking and sustainable materials, celebrity endorsements, and e-commerce expansion further contribute to market growth.

SAN DIEGO, March 10, 2025 /PRNewswire/ -- The Apple Health app provides users with a wide range of metrics to track various health parameters, from heart rate and blood oxygen levels to fall risk and time spent in daylight. Now, Apple Health mobility data can help serve as a valuable tool for assessing patient recovery following lower extremity trauma surgery, such as tibial plateau, distal femur and femoral shaft fractures, according to a study presented at the 2025 Annual Meeting of theAmerican Academy of Orthopaedic Surgeons(AAOS). Using mixed-effect models to compare certain Apple Health mobility parameters, the researchers were able to objectively measure improvement by using a patient's mobility data prior to injury as a baseline metric.

BERLIN, 10. Mrz 2025 /PRNewswire/ -- Laifen, ein fhrender Innovator im Bereich der Krperpflegetechnologie, ist stolz darauf, die offizielle europische Markteinfhrung des Laifen Mini High-speed Haartrocknerin Europa bekannt zu geben, der ultimativen Beauty-on-the-go-Lsung. Pnktlich zum Frhjahr ist der Mini der perfekte Reisebegleiter. Er kombiniert leistungsstarke Leistung, Tragbarkeit und elegantes Design und erfllt damit die Anforderungen moderner Menschen, die viel unterwegs sind. Um diesen Meilenstein zu feiern, bietet Laifen auerdem exklusive Frhlings-Verkaufsaktionen mit Rabatten von bis zu 30 % durch.

BERLIN, March 10, 2025 /PRNewswire/ -- Laifen, a leading innovator in personal care technology, is proud to announce the official European launch of the Laifen Mini Hair Dryer, the ultimate beauty-on-the-go solution. Just in time for Spring, the Mini is the perfect travel companion, combining powerful performance, portability, and stylish design to meet the needs of modern, on-the-move individuals. To celebrate this milestone, Laifen is also rolling out exclusive Spring Sales promotions with discounts of up to 30% off.

BERLIN, 10 de marzo de 2025 /PRNewswire/ -- Laifen, lder en innovacin en tecnologa de cuidado personal, se enorgullece de anunciar el lanzamiento oficial en Europa del secador de pelo Laifen Mini, la solucin definitiva para la belleza en movimiento. Justo a tiempo para la primavera, el Mini es el compaero de viaje perfecto, ya que combina un rendimiento potente, portabilidad y un diseo elegante para satisfacer las necesidades de las personas modernas y en constante movimiento. Para celebrar este hito, Laifen tambin est lanzando promociones exclusivas de rebajas de primavera con descuentos de hasta el 30 %.

LONDON, March 10, 2025 /PRNewswire/ -- Hagen-Dazs is proud to announce the five remarkable winners of The Rose Project, Class of 2024, in celebration of International Women's Day and Women's History Month. The global initiative, created to celebrate the brand's female co-founder, Rose Mattus, sought nominations from across the globe to celebrate groundbreaking women making a societal or community impact.

LONDON, March 10, 2025 /PRNewswire/ -- Hagen-Dazs is proud to announce the five remarkable winners of The Rose Project, Class of 2024, in celebration of International Women's Day and Women's History Month. The global initiative, created to celebrate the brand's female co-founder, Rose Mattus, sought nominations from across the globe to celebrate groundbreaking women making a societal or community impact.